Spectral AI, Inc. reported its financial results for the first quarter of 2026, revealing a significant decline in revenue and an increase in net loss compared to the same period in 2025. The company generated $3.99 million in research and development revenue, a decrease of 40.5% from $6.71 million in the prior year. This decline was primarily attributed to reduced activity under the Biomedical Advanced Research and Development Authority (BARDA) contract, which has been a major source of funding for the company. The gross profit for the quarter was $2.03 million, resulting in a gross margin of 50.8%, up from 47.2% in the previous year.
The company's net loss for the quarter was $3.41 million, compared to a net income of $2.90 million in the same quarter of 2025. This shift was influenced by a substantial change in the fair value of warrant liabilities, which resulted in a loss of $1.00 million in the current quarter, contrasting with a gain of $4.25 million in the prior year. Operating costs remained relatively stable, with general and administrative expenses slightly decreasing to $4.00 million from $4.06 million.
In terms of operational developments, Spectral AI has been focusing on the commercialization of its DeepView System, which received UKCA marking for burn indications in February 2024. The company is also preparing for a De Novo application submission to the FDA for Class II medical device designation. As of March 31, 2026, the company had 31,823,895 shares of common stock outstanding, reflecting an increase from the previous quarter, and an accumulated deficit of $59.21 million.
Looking ahead, Spectral AI anticipates initial sales of the DeepView System in the UK in 2026, supported by ongoing contracts with BARDA and other governmental agencies. The company has received a contract modification from BARDA, providing an additional $31.7 million for further development and procurement activities related to the DeepView System. This funding is expected to bolster the company's efforts in expanding its market presence and enhancing product adoption rates. Despite the current financial challenges, the company believes it has sufficient working capital to fund operations for at least one year, contingent on the successful execution of its strategic plans.
About Spectral AI, Inc.
Spectral AI, Inc. develops AI-powered diagnostic tools for wound assessment, focusing on burn and tissue healing indications. Its DeepView System uses multispectral imaging and proprietary algorithms to predict wound healing potential, aiding clinicians in early, accurate treatment decisions. The company targets hospitals, burn centers, and emergency rooms, leveraging government contracts and strategic partnerships to commercialize its innovative, non-invasive medical diagnostics.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.